[
  {
    "ts": "2026-01-27T14:46:47+00:00",
    "headline": "Regeneron (REGN) Posted Solid Quarterly Results, Eyes 2026 Pipeline Catalysts",
    "summary": "Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its fourth-quarter 2025 investor letter for the “Baird Chautauqua International and Global Growth Fund”. A copy of the letter can be downloaded here. Global equities finished 2025 strongly, with international markets delivering their widest outperformance versus U.S. equities since the Global Financial […]",
    "url": "https://finance.yahoo.com/news/regeneron-regn-posted-solid-quarterly-144647877.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "04c4f6d0-6411-368e-bdaa-09a4b4487f61",
      "content": {
        "id": "04c4f6d0-6411-368e-bdaa-09a4b4487f61",
        "contentType": "STORY",
        "title": "Regeneron (REGN) Posted Solid Quarterly Results, Eyes 2026 Pipeline Catalysts",
        "description": "",
        "summary": "Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its fourth-quarter 2025 investor letter for the “Baird Chautauqua International and Global Growth Fund”. A copy of the letter can be downloaded here. Global equities finished 2025 strongly, with international markets delivering their widest outperformance versus U.S. equities since the Global Financial […]",
        "pubDate": "2026-01-27T14:46:47Z",
        "displayTime": "2026-01-27T14:46:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7388cae081bf4d43e11b4ffb83909080",
          "originalWidth": 640,
          "originalHeight": 427,
          "caption": "Regeneron (REGN) Posts Solid Q3 Results, Eyes 2026 Pipeline Catalysts",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8VsOO3k1Lp3o6xcDP7QwHg--~B/aD00Mjc7dz02NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7388cae081bf4d43e11b4ffb83909080.cf.webp",
              "width": 640,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wGioBSujFOU6exYU8J9gew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7388cae081bf4d43e11b4ffb83909080.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-regn-posted-solid-quarterly-144647877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-regn-posted-solid-quarterly-144647877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-27T17:15:00+00:00",
    "headline": "Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why",
    "summary": "CRVS stock surges 209% in a month after positive cohort 4 phase I data show durable eczema responses for soquelitinib.",
    "url": "https://finance.yahoo.com/news/corvus-pharmaceuticals-stock-rallies-209-171500852.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a7f9047b-dbe9-3449-b73d-c9faded32862",
      "content": {
        "id": "a7f9047b-dbe9-3449-b73d-c9faded32862",
        "contentType": "STORY",
        "title": "Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why",
        "description": "",
        "summary": "CRVS stock surges 209% in a month after positive cohort 4 phase I data show durable eczema responses for soquelitinib.",
        "pubDate": "2026-01-27T17:15:00Z",
        "displayTime": "2026-01-27T17:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rbSgl25Zi2GiiDMk0hXrSg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NAknAcj0fz57CxpyeoYG3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/corvus-pharmaceuticals-stock-rallies-209-171500852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/corvus-pharmaceuticals-stock-rallies-209-171500852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]